Monocyte count and decline in forced vital capacity (FVC) in patients with IPF

A. Tzouvelekis (Athens, Greece), T. Maher (London, United Kingdom), N. Goh (Melbourne, Victoria, Australia), M. Kreuter (Heidelberg, Germany), V. Cottin (Lyon, France), B. Schinzel (Ingelheim am Rhein, Germany), L. Orsatti (Ingelheim am Rhein, Germany), T. Corte (Sydney, New South Wales, Australia)

Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Session: Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Session type: E-poster session
Number: 721
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Tzouvelekis (Athens, Greece), T. Maher (London, United Kingdom), N. Goh (Melbourne, Victoria, Australia), M. Kreuter (Heidelberg, Germany), V. Cottin (Lyon, France), B. Schinzel (Ingelheim am Rhein, Germany), L. Orsatti (Ingelheim am Rhein, Germany), T. Corte (Sydney, New South Wales, Australia). Monocyte count and decline in forced vital capacity (FVC) in patients with IPF. 721

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Forced vital capacity (FVC) decline in idiopathic pulmonary fibrosis (IPF) – modelling the myth
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019


The acceptability criterion for the difference between the forced inspiratory vital capacity (FIVC) and the forced vital capacity (FVC) are too strict?
Source: Virtual Congress 2021 – Future advances in respiratory physiology
Year: 2021


Is the forced expiratory volume in 6 seconds (FEV6) a more reproducible and accurate measurement than forced vital capacity (FVC) in obstructive and normal/restrictive patients
Source: Eur Respir J 2001; 18: Suppl. 33, 13s
Year: 2001

FVC decline over 1 year predicts mortality but not subsequent FVC decline in patients with IPF
Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside
Year: 2017


Forced vital capacity and forced expiratory volume in six seconds as predictors of reduced total lung capacity
Source: Eur Respir J 2008; 31: 391-395
Year: 2008



Osteoprotogerin plasma concentrations is correlate with forced expiratory volume at 1 second (FEV1) in patients with COPD
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013


The inclusion of peak expiratory flow (PEF) among selection criteria of the ”best test“ may increase diagnostic ability of forced vital capacity (FVC)
Source: Eur Respir J 2001; 18: Suppl. 33, 202s
Year: 2001

Is inspiratory capacity (IC) better correlated with functional exercise capacity than FEV1 in COPD patients?
Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases
Year: 2012


Association between weight loss and decline in FVC in patients with IPF
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019


Forced expiratory volume in one second (FEV1) and peak expiratory flow (PEF): is there a correlation in chronic obstructive pulmonary disease (COPD) patients?
Source: Eur Respir J 2001; 18: Suppl. 33, 213s
Year: 2001

Improved survival with increased IC/TLC ratio, DLCO and FEV1 in an analysis of a COPD pulmonary function database
Source: Annual Congress 2011 - Lung and airway function
Year: 2011


Percent predicted forced vital capacity (FVC) is a reliable, valid, and responsive measure of clinical status in patients with idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2010 - Clinical issues in idiopathic pulmonary fibrosis
Year: 2010

Distinguishing hyperinflation from combined restriction in patients with reduced FEV1/FVC and FVC on spirometry
Source: Eur Respir J 2006; 28: Suppl. 50, 202s
Year: 2006

FEV6 and FEV1/FEV6 have higher association with small airway function and oxygen saturation than FVC and FEV1/FVC in patients with asthma.
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020

The relationship between peak expiratory flow rate (PEFR) and forced expiratroy volume in the first second (FEV1) at low levels of FEV1. Implications for the assessment of COPD (chronic obstructive pulmonary disease) in primary care
Source: Eur Respir J 2002; 20: Suppl. 38, 397s
Year: 2002

Changes in spirometry (FVC and FEV1) in a closed population of COPD patients using new standarized values for Mexican people
Source: Eur Respir J 2003; 22: Suppl. 45, 69s
Year: 2003

Midflows do not vary independently of FEV1 and FVC
Source: Annual Congress 2010 - Quality measurement and improvement in lung function
Year: 2010


FEF25-75% should not yet be used to define a bronchodilator response in individuals
Source: Annual Congress 2005 - Spirometry - now and in the future
Year: 2005


Ratio between forced expiratory flow between 25% and 75% of VC and FVC as a determinant of airway reactivity and sensitivity to methacholine
Source: Eur Respir J 2006; 28: Suppl. 50, 219s
Year: 2006

Correlation between spirometric indices (FEV1, FVC) and lung diffusion values (DLCO) in subjects with varying severity of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007